ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,943,000 | -33.6% | 822,012 | -14.8% | 0.29% | -15.9% |
| Q4 2021 | $39,045,000 | +71.7% | 964,782 | +47.9% | 0.35% | +74.7% |
| Q3 2021 | $22,744,000 | +20.5% | 652,240 | -5.1% | 0.20% | +28.6% |
| Q2 2021 | $18,880,000 | -6.6% | 687,540 | -4.4% | 0.15% | -11.0% |
| Q1 2021 | $20,205,000 | -5.9% | 719,540 | -13.0% | 0.17% | -0.6% |
| Q4 2020 | $21,476,000 | +47.3% | 827,270 | -2.8% | 0.17% | +27.0% |
| Q3 2020 | $14,582,000 | -33.4% | 850,770 | -3.9% | 0.14% | -34.4% |
| Q2 2020 | $21,892,000 | – | 884,870 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |